Prostate Cancer Clinical Trials in Tennessee

Showing 221-240 of 307 trials

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

NCT00770822

This study will compare high intensity focused ultrasound to standard brachytherapy in the treatment of primary, organ confined prostate cancer.

Prostate Cancer

SonaCare Medical466 participantsStarted Apr 2007

Birmingham, Alabama, United States • Naples, Florida, United States • Myrtle Beach, South Carolina, United States +3 more locations

COMPLETEDPhase 329 miles

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

NCT00988208

The purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with metastatic Castrate-Resistant Prostate Cancer. The addition of lenalidomide to docetaxel and prednisone is proposed to increase the life expectancy of these subjects.

Prostate Cancer

Celgene1,059 participantsStarted Nov 2009

Phoenix, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +207 more locations

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Vidaza to Restore Hormone Thx Prostate

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

CHESS: Human and Computer Mentors for Prostate Cancer Patients

Other Conditions in Tennessee